George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 200,000 shares at $40.21 ($8.1M) on 2022-05-26, disclosed to the SEC on 2022-05-31.
Open-market sale of $8.1M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.21 | 86,026 | $3.5M | 42.9% |
| 2 | $40.21 | 86,026 | $3.5M | 42.9% |
| 3 | $40.77 | 13,974 | $570K | 7.1% |
| 4 | $40.77 | 13,974 | $570K | 7.1% |
| Total | $40.29 avg | 200,000 | $8.1M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |